Document is current
Any future updates will be listed below
-
Authors
Wu, Jingjing
Ge, Ying
Zhang, Li
Huang, Juan
Huang, Nanqu
Luo, Yong
-
Funding
Funding for this research was provided by:
Science and Technology Department of Guizhou Province (ZK [2024]-680)
Science and Technology Department of Guizhou Province (ZK [2021]-570)
National Natural Science Foundation of China (82160858)
Zunyi Science and Technology Bureau (HZ-2022-45, [2024] No. 6, HZ-2025-06)
Guizhou Provincial Science and Technology Department (ZSYS(2025)040)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 27 February 2026
First Online: 17 March 2026
Declarations
:
: The animal experiments were conducted in line with the ARRIVE guidelines 2.0. The study protocol titled “Mechanistic Study of Tanshinone IIA-Conditioned Mesenchymal Stem Cells Regulating TREM2/DAP12 Signaling Pathway in the Treatment of Alzheimer’s Disease Neuroinflammation” (Approval No. (2019)2-231, 11 Mar 2019) was reviewed and approved by the Ethical Committee for Animal Experiments of Zunyi Medical University. All animal experiments were performed under ethical supervision.
: The authors declare no competing interests.
